KRISTINE BAILEY: Open Payments
NPI 1669653952 · LAKEWOOD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 30 payments from 10 companies in 2025. Trend: 2023 $368 · 2024 $363 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $174 |
| Otsuka America Pharmaceutical, Inc. | 5 | $110 |
| Lundbeck LLC | 2 | $44 |
| Collegium Pharmaceutical, Inc. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| Alkermes, Inc. | 1 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: VRAYLAR, REXULTI, Jornay PM, COBENFY, Qelbree, ARISTADA, ABILIFY ASIMTUFII, INGREZZA.
Industry payments across NY — which companies pay providers there.
